Sort
78,016 grants matching “breast cancer”
VDX-111: A novel targeted therapeutic for triple-negative breast cancer
$995,137Cherie Lambert · Vona Oncology, Llc · R44 · FY2024 · CA
Building a Sustainable Indian Tribal Infrastructure for Translational Research
$995,133Carolyn June Strickland · University Of Washington · RC4 · FY2010 · NR
Development of VNLG-152R as novel therapeutic for triple negative breast cancer
$995,100Vidya P Ramamurthy · Isoprene Pharmaceuticals, Inc. · R44 · FY2021 · CA
Development of VNLG-152R as novel therapeutic for triple negative breast cancer
$995,100Vidya P Ramamurthy · Isoprene Pharmaceuticals, Inc. · R44 · FY2022 · CA
Tumor Immune Contexture and Breast Cancer Disparities: A Multi-Disciplinary Study in Women of African and European Ancestry
$994,901Christine B. Ambrosone · Roswell Park Cancer Institute Corp · R01 · FY2020 · CA
Rapid Identification of Pathogenic Bacteria and Sepsis Diagnosis
$994,871Ray Anthony Martino · Isense, Llc · R44 · FY2013 · AI
Leadership, Planning and Evaluation
$994,847Caryn Lerman · University Of Southern California · P30 · FY2023 · CA
BAY AREA BREAST CANCER TRANSLATIONAL RESEARCH PROGRAM
$994,561University Of California San Francisco · P50 · FY2002 · CA
3D Bioprinted lung cancer models for drug screening
$994,549Marc Ferrer · National Center For Advancing Translational Sciences · ZIA · FY2024 · TR
Building Sustainable Community-based Research Infrastructure to Better Science (C
$994,445Marion Helen Eloise Kavanaugh-Lynch · University Of California Sys Office/Pres · RC4 · FY2010 · ES
Estrogen Metabolites, Related Genes and Breast Cancer
$994,129New York University School Of Medicine · R01 · FY2003 · CA
Enabling clinical tissue microstructure imaging as a diagnostic tool in wide-bore 3T MRI
$993,663Thomas K Foo · Ge Medical Systems Information Technologies, Inc · U01 · FY2024 · EB
Cancer Deep Phenotype Extraction from Electronic Medical Records
$993,015Guergana K. Savova · Boston Children'S Hospital · U24 · FY2018 · CA
Tumor Immune Contexture and Breast Cancer Disparities: A Multi-Disciplinary Study in Women of African and European Ancestry
$993,003Christine B. Ambrosone · Roswell Park Cancer Institute Corp · R01 · FY2022 · CA
Developing novel LOX inhibitors to target chemotherapy resistant TNBC
$992,932Ozgur Sahin · Loxigen, Inc. · R42 · FY2024 · CA
Immunomodulatory biomaterial to enhancing T-cell responses to triple negative breast cancer
$992,724Dashtimoghadam Erfan · Symphony Biosciences, Inc. · R44 · FY2024 · CA
Molecular, Cellular, and Tissue Characterization Unit
$992,570William E Gillanders · Washington University · U2C · FY2020 · CA
Bay Area Cancer Target Discovery and Development
$992,465Michael T McManus · University Of California, San Francisco · U01 · FY2025 · CA
Randomized Prospective Trial of Breast Cancer Locator Guided vs. Wire Localized Partial Mastectomy for Breast Cancer
$992,343Venkataramanan Krishnaswamy · Cairnsurgical, Inc. · R44 · FY2021 · CA
Human natural killer cells: Advancing biology and clinical applications
$992,214Michael A Caligiuri · Beckman Research Institute/City Of Hope · R35 · FY2018 · CA
Robust Predictor of Breast Cancer Risk
$991,797Harry Ostrer · Morgan And Mendel Genomics, Inc. · R42 · FY2020 · CA
Characterization of Cancer Stem Cells
$991,766William Farrar · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
Elucidating and Targeting tumor dependencies and drug resistance determinants at the single cell level
$991,182Andrea Califano · Columbia University Health Sciences · U01 · FY2022 · CA
Commercializing Praedicare Dx TM platform for guiding cancer treatments
$991,179Michael H Cardone · Eutropics Pharmaceuticals, Inc. · R44 · FY2018 · CA
CCTN - CONTRACEPTIVE EFFICACY AND SAFETY OF DAILY ORAL ULIPRISTAL ACETATE
$991,117Erin Allen · Columbia University Health Sciences · N02 · FY2013 · HD